Two separate Canadian frameworks govern peptide research: sport anti-doping rules and Health Canada’s drug classification system. They ask different questions. Here’s a plain-language guide to both.
A certificate of analysis reports what a lab tested and found — but only if you know what it’s actually measuring. Here’s what a COA does, and does not, prove.
“Shown in a study” can mean a petri dish, a mouse, or a controlled human trial — and those are very different claims. Here’s how to tell them apart and read peptide research responsibly.
Muscle loss isn’t just an “old age” problem — longevity researchers increasingly point to midlife as the real window for prevention. Here’s what the evidence says about training, protein and anabolic resistance.
Mitochondrial function does change with age — but research increasingly shows physical activity, not age alone, drives much of that change. Here’s what the evidence actually shows.
A science-focused overview of Tesofensine research — covering its mechanism as a triple monoamine reuptake inhibitor, the TIPO-1 clinical trial findings, neurological pathways, safety profile, and the limits of current evidence.
A science-focused overview of GHK-Cu (Glycyl-L-Histidyl-L-Lysine Copper) research — covering tissue remodelling, hair follicle biology, antioxidant properties, and the limits of current evidence.
Recovery does not suddenly change at 35. Explore what sports science says about muscle, tendon adaptation, training status and recovery across midlife.
